benzoxazoles has been researched along with Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kiełbik, A; Kulbacka, J; Novickij, V; Rembiałkowska, N; Saczko, J; Szewczyk, A; Szlasa, W; Tarek, M | 1 |
Arnér, ES; Brodin, B; Campbell, J; Drummond, CJ; Higgins, M; Laín, S; McCarthy, AR; Sachweh, MC; Stafford, WC | 1 |
2 other study(ies) available for benzoxazoles and Melanoma
Article | Year |
---|---|
Oxidative Effects during Irreversible Electroporation of Melanoma Cells-In Vitro Study.
Topics: Benzoxazoles; Cell Membrane; Cell Membrane Permeability; Electroporation; Humans; In Vitro Techniques; Lipids; Melanoma; Oxidative Stress; Quinolinium Compounds; Skin Neoplasms; Tumor Cells, Cultured | 2020 |
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.
Topics: Animals; Antineoplastic Agents; Auranofin; Benzothiazoles; Benzoxazoles; Cell Line, Tumor; Cell Survival; Enzyme Activation; Glutathione; Glutathione Reductase; HCT116 Cells; Humans; Imidazoles; Indoles; Melanoma; Mice; Oxidation-Reduction; Oxidative Stress; Piperazines; Reactive Oxygen Species; Sulfonamides; Sulfones; Thioredoxin Reductase 1; Tumor Suppressor Protein p53; Vemurafenib | 2015 |